Millennium Management LLC 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 4:00 pm Sale | 2024-12-31 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 3,919,131 4.600% | -1,446,090 (-26.95%) | Filing |
| 2024-09-09 4:36 pm Purchase | 2024-08-30 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 5,365,221 6.300% | 1,064,216 (+24.74%) | Filing |
| 2024-06-27 4:42 pm Purchase | 2024-06-21 | 13G | Verve Therapeutics, Inc. VERV | Millennium Management LLC | 4,301,005 5.100% | 4,301,005 (New Position) | Filing |